Bank of America
PRME icon

Bank of America’s Prime Medicine PRME Stock Holding History

Bank of America’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.01M Sell
577,004
-71,008
-11% -$270K ﹤0.01% 4118
2025
Q4 		$2.25M Buy
648,012
+537,170
+485% +$2.39M ﹤0.01% 3974
2025
Q3 		$614K Sell
110,842
-33,669
-23% -$137K ﹤0.01% 5654
2025
Q2 		$357K Buy
144,511
+31,585
+28% +$48.7K ﹤0.01% 5888
2025
Q1 		$225K Sell
112,926
-317,687
-74% -$810K ﹤0.01% 6109
2024
Q4 		$1.26M Sell
430,613
-54,512
-11% -$191K ﹤0.01% 4832
2024
Q3 		$1.88M Buy
485,125
+57,729
+14% +$267K ﹤0.01% 4609
2024
Q2 		$2.2M Buy
427,396
+5,976
+1% +$36.2K ﹤0.01% 4375
2024
Q1 		$2.95M Sell
421,420
-49,176
-10% -$373K ﹤0.01% 4119
2023
Q4 		$4.17M Buy
470,596
+167,954
+55% +$1.29M ﹤0.01% 3701
2023
Q3 		$2.89M Buy
302,642
+155,127
+105% +$2.01M ﹤0.01% 3915
2023
Q2 		$2.16M Sell
147,515
-2,752
-2% -$38.4K ﹤0.01% 4162
2023
Q1 		$1.85M Buy
150,267
+102,908
+217% +$1.68M ﹤0.01% 4414
2022
Q4 		$880K Buy
+47,359
New +$855K ﹤0.01% 4950

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Bank of America's PRME Position: Q1 2026 in Review

Bank of America reduced its Prime Medicine (PRME) stake by 11% in Q1 2026, selling an estimated $270K and leaving 577,004 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #4118.

Bank of America first reported a position in PRME in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.17M in Q4 2023. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Bank of America held 577,004 shares of Prime Medicine worth $2.01M as of Q1 2026.
  • Bank of America sold 71,008 Prime Medicine shares in Q1 2026, an estimated $270K.
  • Prime Medicine made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4118 holding.
  • Bank of America first reported a position in Prime Medicine in Q4 2022 and has held it in 14 quarters since.
  • Bank of America's Prime Medicine position peaked at $4.17M in Q4 2023.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.